Treatment of hyperhidrosis can be divided into topical, oral, surgical, and nonsurgical treatments (botulinum toxin). These therapeutic options differ with respect to their efficacy, duration of ...

Scalp folliculitis is a skin condition that occurs when the hair follicles on the scalp become inflamed. This results in ...

Cold sores, sore throats, migraines and conjunctivitis are among the conditions which will no longer be treated on the NHS by ...

Stock analysts at Roth Capital boosted their FY2024 EPS estimates for Journey Medical in a research note issued on Monday, November 4th. Roth Capital analyst J. Wittes now anticipates that the company ...

The company's FDA-approved drug Sofdra is the first for the common and embarrassing condition of excessive sweating.

This development is part of Botanix’s strategy to expand payer coverage, now reaching over 110 million commercial lives, for its novel treatment targeting primary axillary hyperhidrosis, a condition ...

Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its ...

The U.S. Food and Drug Administration has approved Journey Medical's Emrosi (minocycline hydrochloride) for the treatment of ...

Doctors have been fairly quick to jump on the biologics train: According to Spherix, 96% of dermatologists reported using ...

Acne treatments include prescription medications, such as topical and oral varieties, and over-the-counter (OTC) skin care products. To narrow the vast list of options, we enlisted the expertise ...

The Food and Drug Administration has approved Emrosi ™ (minocycline hydrochloride extended-release capsules) for the treatment of inflammatory lesions (papules and pustules) of rosacea in adults. In ...